Thioredoxin downregulation enhances sorafenib effects in hepatocarcinoma cells

CARMEN ALICIA PADILLA PEÑAJOSÉ ANTONIO BÁRCENA RUIZ2026-01-292026-01-29201910.3390/antiox81005012-s2.0-85074226007https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30986BiochemistryCell BiologyClinical BiochemistryFood ScienceMolecular BiologyPhysiologyThioredoxin downregulation enhances sorafenib effects in hepatocarcinoma cellsresearch article